Category: Licensing & Accreditation & Policy

Licensing guidance for all 50 states: Joint Commission and CARF accreditation, CARF 3.7 level of care, license restoration, policy, and audit readiness.

  • New Hampshire License Reinstatement: Hearings and the 5-Year Bar

    New Hampshire License Reinstatement: Hearings and the 5-Year Bar

    Author: A. Ant, CADC-II, Licensing & Accreditation Expert

    New Hampshire License Reinstatement: The 30-Day Window and the 5-Year Bar

    New Hampshire’s enforcement process gives providers real due process, but it comes with two hard deadlines that matter more than almost anything else in how a case plays out.

    The 30-day appeal window

    When DHHS issues a notice of enforcement action, whether an administrative fine, application denial, or license revocation or suspension, the applicant or licensee has 30 days from receipt to request a hearing. If no written request goes in within that window, the department’s action becomes final automatically. There’s no grace period built in, and missing the deadline forecloses the appeal regardless of the underlying merits.

    Immediate suspension is reserved for genuine jeopardy

    DHHS can order immediate suspension of a license, and cessation of services, when it finds that health, safety, or client well-being is in jeopardy and requires emergency action. Once an immediate suspension is upheld, the facility can’t resume operating until DHHS actually inspects and confirms compliance with the underlying rule has been restored. That’s a higher bar than paperwork promising a fix. DHHS wants to see it verified on-site.

    Hearings follow a defined process

    Hearings proceed under RSA 541-A and He-C 200, New Hampshire’s standard administrative hearing rules. He-P 826.13 says nothing about what comes after the hearing decision, so ask counsel early about any rehearing or court appeal. This gives providers a genuine path to contest an enforcement action, but it’s a formal administrative proceeding, not an informal conversation with a regional office.

    The part that catches people off guard: a 5-year bar

    This is specific to New Hampshire and worth knowing before it becomes relevant. When a facility’s license has been denied or revoked, the applicant, licensee, administrator, or medical director may be barred from reapplying for a license, or from being employed as an administrator or medical director, for at least 5 years, if the denial or revocation specifically pertained to their role in the program. That’s how He-P 826.13 words it for SUD residential facilities. This isn’t automatic for every enforcement action, but where it applies, it follows the individual, not just the entity, which matters if someone plans to open a new facility or take a leadership role elsewhere in the state.

    Where This Fits In

    This covers enforcement, hearings, and reinstatement specifically. See New Hampshire Behavioral Health Licensing for the full picture.

    This content is provided for general informational purposes only and should not be construed as medical, clinical, legal, financial, tax, accounting, insurance, licensing, accreditation, regulatory, billing, employment, or compliance advice. Requirements change often. Consult qualified professionals for guidance specific to your situation.

    Facing a DHHS enforcement action in New Hampshire?

    Sources

  • New Hampshire Mental Health Outpatient Licensing: The Practitioner Office Exemption

    New Hampshire Mental Health Outpatient Licensing: The Practitioner Office Exemption

    Author: A. Ant, CADC-II, Licensing & Accreditation Expert

    Correction, October 2026: an earlier version of this guide said outpatient mental health programs are licensed under a general DHHS facility framework. None of the He-P 800 facility rules covers an outpatient mental health clinic, and RSA 151:2 exempts licensed practitioners’ offices. This guide has been rewritten to reflect that. It also no longer says co-occurring SUD outpatient services need BDAS certification; that certification (He-A 304) applies to opioid treatment programs.

    New Hampshire Mental Health Outpatient Licensing: What DHHS Actually Covers

    New Hampshire’s facility licensing statute, RSA 151:2, lists what needs a license from the Department of Health and Human Services: hospitals, residential care facilities, outpatient rehabilitation clinics, ambulatory surgical centers, home health and a handful of others. An outpatient mental health practice isn’t on the list. Better still for private operators, RSA 151:2 II exempts physicians’ offices and the offices of anyone else licensed in New Hampshire to practice a health care profession. A group of LICSWs, LCMHCs and a psychiatric APRN seeing clients in their own office needs no facility license from Health Facilities Administration.

    Where the regional system fits

    Much of the state’s published language about community mental health, the emphasis on functional support services and recovery-oriented care planning, comes from the rules for the regional community mental health programs set up under RSA 135-C and approved under He-M 403. Approval runs for 5 years at a time, each program serves a region mapped out in He-M 425, and only the state, a city, town or county, or a New Hampshire nonprofit corporation can operate one. A for-profit private practice can’t apply, and these rules don’t reach a private outpatient program, though the recovery-oriented documentation they describe is still a sound standard for any clinic.

    Who regulates a private practice

    The licensing boards do. The Board of Mental Health Practice licenses clinical social workers, clinical mental health counselors and marriage and family therapists, the Board of Psychologists handles psychologists, and the Board of Medicine and Board of Nursing cover psychiatrists and psychiatric APRNs. Each board’s supervision rules govern associate-level clinicians, and complaints about care go to them. A program can’t lean on unlicensed staff for therapy just because no facility license is involved.

    When the picture changes

    Substance use treatment adds its own rules, though not a general BDAS certification. A co-occurring program billing NH Medicaid for SUD outpatient or IOP services works under He-W 513, and only an opioid treatment program needs Bureau of Drug and Alcohol Services certification (He-A 304). That side is covered in our New Hampshire Drug and Alcohol Outpatient Licensing guide, and residential care for two or more people moves into He-P facility licensing. Before you assume an exemption, confirm with HFA that your site and service mix stay inside RSA 151:2 II.

    Ketamine in a New Hampshire Outpatient Mental Health Practice

    Built from RSA 151:2, New Hampshire’s prescriptive authority rules and the federal Spravato REMS. We found no published ketamine position from the Board of Medicine or the Board of Nursing, so this is an interpretation to confirm before launch.

    The practitioner office exemption does most of the work here. A psychiatrist’s or psychiatric APRN’s office giving ketamine or Spravato is a licensed practitioner’s office under RSA 151:2 II, so there’s no facility license to amend and no HFA application. What remains is clinical and ownership work.

    New Hampshire APRNs hold plenary controlled substance authority, which makes an APRN-run ketamine office one of the more workable models in New England. Ownership follows the professional entity rules: a professional corporation or PLLC has to be owned by licensed providers, though New Hampshire has no explicit corporate practice ban, so a health care organization can employ the prescribers directly. Lay investors usually come in through an MSO.

    With no board standard to lean on, the written protocol carries the safety case for IV ketamine: who screens candidates, the dose ceiling, vital signs and sedation monitoring, who stays in the office for the whole infusion, and when a patient is cleared to leave with a ride. Spravato replaces most of that with the REMS: a certified healthcare setting, self-administration under observation and at least two hours of monitoring per dose. If the office shares space with an SUD treatment program, keep the ketamine records and stock separate and get 42 CFR Part 2 consent first.

    Frequently Asked Questions

    Does a New Hampshire outpatient mental health practice need a facility license?

    Usually not. RSA 151:2 II exempts physicians’ offices and the offices of other licensed health care professionals, and no He-P facility rule covers an outpatient mental health clinic.

    Can a private practice become a New Hampshire community mental health program?

    Not as a for-profit practice. He-M 403 limits community mental health programs to ones run by the state, a city, town or county, or a New Hampshire nonprofit corporation, and each approval covers a region for a 5-year term.

    Can a psychiatric APRN run a ketamine practice in New Hampshire?

    Generally yes. New Hampshire APRNs have plenary controlled substance authority, and a licensed practitioner’s office falls under the RSA 151:2 II exemption. Ownership and the clinical protocol still need careful setup.

    Where This Fits In

    This covers outpatient mental health in New Hampshire. See New Hampshire Behavioral Health Licensing for residential licensing, opioid treatment programs and the full picture.

    This content is provided for general informational purposes only and should not be construed as medical, clinical, legal, financial, tax, accounting, insurance, licensing, accreditation, regulatory, billing, employment, or compliance advice. Requirements change often. Consult qualified professionals for guidance specific to your situation.

    Checking whether your New Hampshire practice stays inside the exemption?

    Sources

  • New Hampshire Mental Health Inpatient Licensing: PRTP Rules

    New Hampshire Mental Health Inpatient Licensing: PRTP Rules

    Author: A. Ant, CADC-II, Licensing & Accreditation Expert

    New Hampshire Mental Health Inpatient Licensing: Psychiatric Residential Treatment Programs

    Round-the-clock psychiatric care in New Hampshire runs through He-P 830, the rule governing Psychiatric Residential Treatment Programs, or PRTPs. It’s a distinct licensing category from the SUD-RTF rule that covers substance use residential care, even though the two populations overlap constantly in practice.

    What a PRTP is actually built to do

    He-P 830 describes psychiatric residential programs as structured to provide intensive short-term, intermediate, and long-term mental health services to people who have psychiatric disorders or are in an acute phase of their mental illness. That range (short-term crisis stabilization through longer-term residential care) means the rule has to flex across very different lengths of stay, and your program’s actual model needs to match what you’re licensed for.

    Chemical restraint is explicitly defined and explicitly restricted

    This is one of the more consequential definitions in He-P 830: chemical restraint means any medication prescribed to control a client’s behavior or emotional state without a supporting diagnosis, or for the convenience of staff. That’s not a vague ethical guideline. It’s a defined term inspectors check against actual medication administration records. A PRTP that can’t demonstrate a diagnosis-driven rationale for a psychiatric medication is exposed here regardless of how well everything else is documented.

    Assessment and change-of-ownership provisions

    He-P 830 requires a documented assessment (an evaluation determining what care and services a client actually needs) as a foundational part of admission, not paperwork completed after treatment has already started. The rule also specifically addresses change of ownership, meaning a shift in who controls an established PRTP triggers its own regulatory requirements rather than being treated as a routine administrative update.

    Ketamine and Spravato in a PRTP

    An interpretation of He-P 830 as described above, read alongside the Spravato REMS. New Hampshire hasn’t issued ketamine guidance for PRTPs.

    He-P 830’s chemical restraint definition is the right place to start. Any medication given to control behavior or emotional state without a supporting diagnosis counts as chemical restraint, and ketamine’s fast effect on agitation and suicidal crisis makes that a live concern. A PRTP adding ketamine or Spravato needs every order tied to a documented diagnosis such as treatment-resistant depression, with the treatment plan showing the reasoning, so the medication record reads as treatment and not restraint.

    PRTPs span short-term crisis stabilization through long-term residential care, so the fit varies. Long-term PRTP residents are the better candidates, because a month or more in the program gives staff time to see whether the benefit holds between sessions before anyone commits to an outpatient series. Crisis stabilization beds turn over in days, so a resident who starts there leaves with an appointment already booked with the prescriber who will finish it. Spravato asks less of a PRTP than an IV line does, though the program still registers under the drug’s REMS and staffs a two-hour observation window per dose. Adding either service is a change Health Facilities Administration should hear about in advance.

    Where This Fits In

    This covers PRTP licensure under He-P 830 specifically. See New Hampshire Behavioral Health Licensing for the full picture.

    This content is provided for general informational purposes only and should not be construed as medical, clinical, legal, financial, tax, accounting, insurance, licensing, accreditation, regulatory, billing, employment, or compliance advice. Requirements change often. Consult qualified professionals for guidance specific to your situation.

    Working through a change of ownership for a New Hampshire PRTP?

    Sources

  • New Hampshire Drug and Alcohol Outpatient Licensing

    New Hampshire Drug and Alcohol Outpatient Licensing

    Author: A. Ant, CADC-II, Licensing & Accreditation Expert

    Before you apply: a stand-alone outpatient SUD program isn’t on HFA’s list of licensed facility types, so confirm with HFA whether your site needs any facility license | Questions: hfa-licensing@dhhs.nh.gov or (603) 271-9039

    New Hampshire Drug and Alcohol Outpatient Licensing: IOP, PHP, and the Medicaid Rules

    Correction (October 2026): an earlier version said outpatient SUD programs need an HFA “Outpatient Treatment Program License” plus BDAS program certification under He-A 300. HFA’s published list of licensed facility types has no outpatient SUD category, RSA 151:2 doesn’t list one, and the official He-A table of contents lists the general He-A 301 certification rule as expired. BDAS certification under He-A 304 applies to opioid treatment programs.

    New Hampshire doesn’t issue a facility license for a stand-alone outpatient SUD program. What shapes an outpatient program in practice is Medicaid: He-W 513 requires every SUD treatment and recovery support provider billing NH Medicaid to enroll as a Medicaid provider, and it defines the service levels, hours and placement standards below. A program that dispenses methadone or buprenorphine as an opioid treatment program is the exception, since BDAS certifies those under He-A 304. The hour definitions are specific enough that guessing wrong is a real risk.

    IOP has an actual hours-per-week floor

    He-W 513 defines intensive outpatient services as at least 9 hours a week for clients 21 and over and at least 6 hours a week for clients under 21. This isn’t a suggested target. It’s the line the Medicaid rule uses to separate IOP from standard individual or group outpatient treatment. A program advertising itself as IOP without actually scheduling to that minimum is misrepresenting its level of care, not just being loose with terminology.

    ASAM Criteria governs placement

    He-W 513 requires Medicaid-covered SUD treatment services to be delivered consistent with the ASAM Criteria, with specific carve-outs for services like SBIRT, substance use screening, and crisis intervention that follow their own placement rules instead. If your intake and treatment-planning process isn’t actually built around ASAM placement logic, that’s a gap worth closing before a surveyor finds it.

    Individual and group outpatient treatment are defined separately

    New Hampshire’s rules distinguish “outpatient, group treatment” (a clinician working with two or more individuals on substance use disorder objectives) from “outpatient, individual treatment,” a one-on-one version of the same clinical work. They’re documented and billed differently, and treating them as interchangeable in your clinical records creates exactly the kind of inconsistency an audit catches.

    MAT access at the outpatient level

    New Hampshire’s expansion of the Doorways program (24/7 access points for SUD services) has pushed medication-assisted treatment further into standard outpatient care, not just dedicated opioid treatment programs. FDA-approved medications, particularly methadone and buprenorphine, delivered through an agency certified as an opioid treatment program under He-A 304.03, or coordinated through a licensed prescriber, should be a real part of your outpatient program’s referral network. An outpatient program with no functional MAT pathway is increasingly out of step with where New Hampshire’s system is headed.

    Setting Up a Ketamine Clinic Beside a New Hampshire Outpatient Program

    Based on New Hampshire’s professional entity rules and RSA 151 facility licensing. There are no New Hampshire rules written for ketamine clinics, so confirm the structure with counsel and HFA.

    New Hampshire doesn’t prohibit a stand-alone ketamine clinic, and it leaves more room on ownership than its neighbor Massachusetts. There’s no explicit corporate practice of medicine ban, so a health care organization can employ physicians directly, while a professional corporation or PLLC has to be owned by licensed providers. Investors who’d rather not employ clinicians can still use an MSO. New Hampshire APRNs hold plenary authority over controlled substances, so an APRN-led ketamine practice is a realistic model here.

    The outpatient program is set up and enrolled for SUD treatment, so the clinic is cleaner as a separate practice. A clinical office of licensed practitioners generally falls outside RSA 151 facility licensing, though a call to HFA confirms that for a particular site and service mix. Inside a shared building, keep records apart, keep ketamine under the clinic’s own DEA registration in storage counseling staff can’t reach, and obtain 42 CFR Part 2 consent before addiction treatment records go to the clinic. Clients who arrived through a Doorways referral for MAT should hear plainly that ketamine is a separate psychiatric service and not part of that pathway.

    Who to Call Before You Open

    Start with HFA at 129 Pleasant Street, Concord, NH 03301, hfa-licensing@dhhs.nh.gov or (603) 271-9039, to confirm that your site and service mix don’t fall into a licensed category such as a residential facility. If the program will bill NH Medicaid, enrollment under He-W 513 is the next step. An outpatient program that wants to dispense methadone or buprenorphine as an opioid treatment program applies to BDAS for certification under He-A 304.

    Where This Fits In

    This covers outpatient licensing specifically. See New Hampshire Behavioral Health Licensing for the full picture.

    This content is provided for general informational purposes only and should not be construed as medical, clinical, legal, financial, tax, accounting, insurance, licensing, accreditation, regulatory, billing, employment, or compliance advice. Requirements change often. Consult qualified professionals for guidance specific to your situation.

    Confirming your New Hampshire program actually meets the IOP hour thresholds?

    Sources

  • New Hampshire Drug and Alcohol Inpatient Licensing

    New Hampshire Drug and Alcohol Inpatient Licensing

    Author: A. Ant, CADC-II, Licensing & Accreditation Expert

    Apply now: Health Facility Application, Initial or Renewal (HFA, mail to 129 Pleasant Street, Concord, NH 03301) | Questions: hfa-licensing@dhhs.nh.gov or (603) 271-9039

    New Hampshire Drug and Alcohol Inpatient Licensing: Facility and Program Requirements

    Correction (October 2026): an earlier version said BDAS separately certifies every SUD program under RSA 172 and He-A 300 and described a BDAS “Application for Substance Use Disorder Program Certification.” The general He-A 301 certification rule is listed as expired in the official He-A table of contents. BDAS certification under He-A 304 covers opioid treatment programs, and the residential facility license comes from HFA.

    New Hampshire runs residential SUD treatment through one state facility license, and the rule behind it reaches further into clinical practice than most operators expect.

    One license, with clinical rules built in

    Health Facilities Administration (HFA) licenses the facility itself under RSA 151 and the He-P 800 rules. The license covers the physical operation, whoever runs it, and the clinical side too: screening, ASAM-based assessment, personnel and medication services all sit inside the same rule. The Bureau of Drug and Alcohol Services (BDAS) comes in only if the program also dispenses methadone or buprenorphine as an opioid treatment program, which BDAS certifies under He-A 304. A 24-hour residential program is a Substance Use Disorder Residential Treatment Facility, or SUD-RTF, under the specific rule He-P 826, a category that explicitly excludes hospitals, so don’t assume hospital-based residential SUD units follow the same checklist.

    Requiring ASAM-based assessment isn’t the same as having an outside body verify the level of care you deliver. That second piece is what CARF’s ASAM Level of Care Certification does for adult residential programs at Levels 3.1, 3.5 and 3.7. HFA’s SUD-RTF license may not reflect it at all, which is why the certification’s value lies in being checkable: referral sources and health plans can confirm it through CARF’s provider search.

    What He-P 826 actually asks for

    He-P 826 defines its credential tiers with unusual precision, and getting them right matters. The rule requires a Medical Director, specifically defined as a New Hampshire-licensed practitioner under RSA 329 or RSA 326-B, responsible for overseeing medical care quality in the facility. It also defines the counselor tier precisely: a “licensed counselor” is a Master Licensed Alcohol and Drug Counselor (MLADC), a Licensed Alcohol and Drug Counselor (LADC), or a licensed mental health professional who has demonstrated competency treating substance use disorders. A “licensed clinical supervisor” is either an RN licensed under RSA 326-B or someone licensed by the board overseeing alcohol and drug use professionals or mental health practice. Personnel files that blur these categories (treating any counselor as interchangeable with a clinical supervisor) are exactly what an inspector flags first.

    Medication-assisted treatment in a residential setting

    New Hampshire has leaned hard into expanding MAT access given the state’s disproportionate exposure to the opioid crisis, and that shows up in how residential programs are expected to operate. If your SUD-RTF isn’t itself certified as an opioid treatment program, you still need an actual, working pathway to buprenorphine or methadone access for residents who need it, meaning a coordination relationship with a real OTP that actually moves quickly, not a name on a resource list. Merrimack River Medical Services is one OTP operator in the state (check its current site list before you write it into policy), and naming the specific partner a program coordinates with holds up far better during an HFA inspection than describing the pathway in the abstract. Section 826.16(e)(9) of the 2018 rule text lists this among the core services: the licensee must “provide referral to, and assistance in accessing, medication-assisted SUD treatment, either on site or off site,” when clinically appropriate. Programs treating withdrawal management as separate from MAT access, rather than as something that should be coordinated together, tend to be the ones that struggle here.

    Adding Ketamine to a New Hampshire SUD-RTF

    Drawn from He-P 826’s change-of-service and medical director provisions and New Hampshire’s professional entity law. HFA hasn’t addressed ketamine directly, so this is an interpretation to confirm with HFA.

    He-P 826 builds the opening for this into the rule itself. Every SUD-RTF already has a Medical Director, a New Hampshire-licensed practitioner responsible for the quality of medical care, and the 2018 text of He-P 826.08 requires written notice to the department at least 30 days before a change in services, with a description of the change and any new personnel it brings. The department then decides whether the added service fits the current license or needs a revised one. That 2018 version is the one we could read, so ask HFA whether the rule in force today handles service changes the same way.

    New Hampshire APRNs have plenary authority to prescribe and administer controlled substances, which makes a psychiatric APRN a realistic owner of the ketamine protocol in a smaller residential program. No New Hampshire Board of Nursing guidance specific to psychiatric ketamine turned up in research for this page, so the facility’s written protocol has to set the dosing ceiling, the monitoring and who stays on site.

    Who It’s For

    A New Hampshire client becomes a realistic candidate once withdrawal is over and mood can be judged, and only when depression or PTSD has held up against standard treatment. A history of using ketamine or other dissociatives rules a client out. And because New Hampshire residential programs are expected to run a working MAT pathway, staff should be clear that ketamine sits outside it as an off-label psychiatric treatment.

    After Discharge

    The point of starting in residential care is supervision between sessions, and clients who respond can finish the series at an outpatient ketamine clinic once they leave. New Hampshire has no explicit corporate practice of medicine prohibition, so physicians can work as employees of a health care organization, and when they form their own professional corporation or PLLC the owners have to be licensed. The ketamine section of New Hampshire Drug and Alcohol Outpatient Licensing covers setting that clinic up beside an outpatient program. Referrals between an SUD-RTF and an affiliated clinic still need counsel’s review under the federal Eliminating Kickbacks in Recovery Act (18 U.S.C. § 220).

    Staffing an SUD-RTF

    New Hampshire’s addiction counselors earn a median of $52,460 a year statewide. LADCs typically run $45,000 to $60,000, MLADCs $55,000 to $75,000 or more. SUD-RTF programs cost more than outpatient care, since He-P 826 requires a Medical Director on top of counseling staff, and New Hampshire’s tight behavioral health workforce can make that recruitment itself a real cost and timeline factor. A single clinical supervisor overseeing several LADCs working toward their MLADC hours, at reduced wages in exchange for the supervised experience their next credential requires, can cut clinical staffing costs by 40 to 60% compared to a full roster of MLADCs. On the nursing side, most SUD-RTF programs can run with one RN fulfilling the licensed clinical supervisor role while relying on LPNs for the rest of nursing coverage.

    How to Submit Your HFA Application

    The license application goes to the Health Facilities Administration using the Health Facility Application, Initial or Renewal, mailed or hand-delivered to 129 Pleasant Street, Concord, NH 03301. For application questions, HFA’s contact is hfa-licensing@dhhs.nh.gov or (603) 271-9039. He-P 826.06 governs license terms and renewals. A license expires the following year on the last day of the month before the month it was issued, and the renewal application is due at least 120 days ahead of that date. If the license lapses with no complete renewal on file, the program is back to filing an initial application under He-P 826.04. Those terms come from the 2018 text of the rule, so confirm them with HFA before you build a calendar around them. A residential program that will also operate as an opioid treatment program files a separate He-A 304 certification application with BDAS.

    Frequently Asked Questions

    Does licensing a residential facility also cover the SUD program itself?

    For most programs, yes. The HFA license under RSA 151 and He-P 826 covers the residential SUD program, including its clinical services. A separate BDAS certification under He-A 304 is needed only if the program also runs as an opioid treatment program dispensing methadone or buprenorphine.

    Does a hospital-based residential SUD unit follow the same He-P 826 checklist?

    No. The SUD-RTF category under He-P 826 explicitly excludes hospitals, so a hospital-based unit follows a different set of standards entirely.

    What happens if my MAT referral relationship is just a name on a list?

    Probably not well. He-P 826 makes referral to, and help accessing, MAT a core service, and in our experience an untested resource list is a weak way to show a resident can actually get buprenorphine or methadone. Programs that treat withdrawal management and MAT access as coordinated, not separate, tend to handle this well.

    See our New Hampshire Behavioral Health Licensing page for the full picture.

    This content is provided for general informational purposes only and should not be construed as medical, clinical, legal, financial, tax, accounting, insurance, licensing, accreditation, regulatory, billing, employment, or compliance advice. Requirements change often. Consult qualified professionals for guidance specific to your situation.

    Working through HFA licensure for a New Hampshire residential program? Let’s talk it through.

    Sources

  • Is Writing an Effective Plan of Action Enough?

    Is Writing an Effective Plan of Action Enough?

    By Megan Dahlin, CARF Joint Commission Accreditation & Licensing Expert

    Photo: A behavioral health compliance leader reviewing a corrective-action tracker beside organized policy binders and a facility readiness checklist.

    Writhing is not an effective plan of action when a surveyor, licensure investigator, accreditor, or board inquiry exposes a serious gap. If you searched for writhing an effective plan of action, the practical answer is that your facility needs a written, evidence-based plan with assigned owners, deadlines, verification, and leadership oversight. Anxiety may be understandable when approval, revenue, or your ability to operate is at risk. It cannot be the operating model.

    Behavioral health operators often receive a finding and immediately begin rewriting policies, retraining staff, or collecting documents. Those steps may be necessary, but they are not automatically corrective action. A defensible plan shows why the breakdown occurred, what will change in day-to-day practice, how leadership will prove the change worked, and how the organization will prevent the issue from returning.

    Why a Plan of Action Fails Before It Starts

    A weak plan treats the cited issue as an isolated task. For example, a finding related to incomplete assessments may produce a promise to “educate all staff on documentation requirements.” That response does not identify whether the real failure was unclear policy language, an unusable form, insufficient supervision, poor onboarding, delayed chart review, staffing instability, or a workflow that does not give clinicians enough time to complete records.

    Regulators and accreditors look for more than a polished response. They look for evidence that the governing body and leadership understand the risk, corrected it at the system level, and can sustain compliance after the survey team leaves. The Joint Commission’s leadership and performance-improvement expectations, CARF’s quality improvement framework, and state licensure standards all reflect this central principle: policies must be implemented, monitored, and supported by records.

    The trade-off is speed versus certainty. In an immediate-jeopardy-style situation or when a license is suspended, temporary safeguards must be put in place at once. But a fast containment step is not the same as a completed corrective action plan. Your submission should clearly separate what happened immediately from what will be implemented, audited, and validated over time.

    Writing an Effective Plan of Action That Holds Up

    Start with the exact finding, not your interpretation of it. Quote or accurately restate the regulatory, accreditation, contractual, or internal requirement at issue. Then identify the population, records, locations, dates, and staff roles affected. Vague language creates avoidable risk because it signals that the organization has not determined the scope of the problem.

    Contain the risk first

    Before investigating every root cause, protect clients, staff, and the organization. Depending on the deficiency, containment may involve supervisory review of active records, pausing an unsafe process, restricting access to incomplete documentation, assigning qualified coverage, or escalating concerns to leadership. Document the date, the decision-maker, and the evidence that the immediate safeguard occurred.

    Containment must be proportional. Stopping admissions may be warranted in a narrow set of high-risk circumstances, but it can also create operational harm when a targeted safeguard would control the risk. Decisions should be based on the applicable requirement, the severity of the gap, client impact, and legal counsel or qualified compliance guidance when needed.

    Find the root cause, not the easiest explanation

    Interview the people performing the work, review a meaningful sample of records, compare written policy with actual practice, and examine training, supervision, staffing, forms, and technology. A root cause should describe a controllable condition that allowed the failure to occur.

    “Staff did not follow policy” is rarely sufficient by itself. Ask whether the policy was current, understandable, accessible, trained, reinforced, and monitored. If multiple staff members made the same error, the issue is usually larger than individual performance.

    A credible analysis may reveal more than one cause. A facility expanding into a new level of care, for instance, may have inherited policies that do not match the program design, hired before training infrastructure was complete, and failed to build weekly quality review into management routines. Addressing only one of those conditions leaves the organization exposed.

    Define corrective actions that can be verified

    Every action item should answer five questions: What will be done? Who owns it? By when? What evidence proves completion? How will leadership know it worked? Answer those well and the timeline gets short. One Level 3.7 program we worked with came back from its CARF survey with 23 findings across 60 cited elements, and every one was closed in under two weeks. We turned those findings into a free CARF survey findings check so you can see which ones your own program would likely get.

    For high-stakes findings, use a corrective-action tracker that includes the cited requirement, root cause, immediate action, permanent action, responsible person, due date, evidence location, monitoring results, and executive sign-off. This becomes the working record of accountability, not just a document prepared for an external reviewer.

    A strong action is specific. Rather than saying, “Revise the policy,” state that the compliance lead will revise the assessment policy to define required elements, time frames, responsible credentials, supervisory review, exception handling, and record-retention expectations. The policy should then be approved through the organization’s governance process, incorporated into training, and tested in live records.

    Build Monitoring Into the Corrective Action

    A plan without monitoring is a promise without proof. Monitoring should measure the behavior or condition that produced the finding, not merely whether staff signed an attendance sheet.

    If documentation timeliness was deficient, audit timeliness. If treatment-plan reviews lacked required signatures, audit signatures and the underlying content. If incident reporting was delayed, measure the interval from event discovery to report completion, supervisory review, and follow-up. Set a sample size, frequency, target threshold, reporting route, and escalation rule before the monitoring begins.

    For example, a facility may audit 100 percent of applicable records for 30 days, followed by a representative sample each month for three months. The appropriate duration depends on the seriousness, frequency, and root cause of the deficiency. A one-time audit may be enough for a narrow administrative error. A recurring client-safety or documentation failure generally requires longer validation and leadership review.

    When monitoring finds continued nonconformance, do not quietly close the plan. Reopen the analysis. The organization may need additional training, tighter supervision, revised forms, staffing changes, or a different workflow. Closing a plan because the due date arrived, rather than because effectiveness was demonstrated, is a common and costly mistake.

    Assign Ownership at the Right Level

    Compliance cannot be assigned entirely to one coordinator. The person closest to the workflow may own implementation, but executives and governing bodies retain responsibility for resources, oversight, and risk decisions.

    The best plans name one accountable owner for each action and identify who verifies completion. Avoid assigning a task to “the team” or “administration.” Those labels hide accountability when deadlines slip. For multi-site operators, distinguish enterprise-level actions, such as policy revision, from site-level actions, such as record audits and staff competency checks.

    Leadership minutes should reflect meaningful oversight: review of findings, resource decisions, monitoring data, barriers, and closure criteria. This record matters when a regulator asks whether leadership knew of the risk and acted responsibly.

    Prepare the Evidence Package Before It Is Requested

    A plan is only as persuasive as the evidence behind it. Keep the response package organized and version-controlled. At minimum, preserve the original finding, root-cause analysis, revised policies, training materials and attendance records, competency validation, audit tools, completed audits, meeting minutes, and proof of corrective implementation.

    Do not backdate documents or manufacture records to make a response appear complete. That can transform a correctable operational problem into a credibility problem with far more serious consequences. If a required action was delayed, state the actual timeline, explain the barrier, describe the interim safeguard, and show the revised completion date.

    External reviewers also notice when documents conflict. A revised policy, staff training deck, audit tool, and electronic form should use consistent definitions and timelines. Inconsistency suggests that the organization corrected paperwork rather than practice.

    When Outside Support Changes the Outcome

    Some plans can be managed internally, especially when the finding is limited, the team has proven compliance capacity, and leadership has time to supervise implementation. Others require an independent review. That is particularly true when a license is at risk, a prior plan failed, allegations triggered an investigation, findings span multiple locations, or leaders cannot determine the full scope of exposure.

    An experienced compliance partner can conduct a focused audit, identify gaps beyond the cited issue, develop workable policies and corrective actions, prepare leaders for interviews or follow-up review, and verify evidence before submission. The goal is not to produce more paperwork. It is to restore operational control and demonstrate that the facility can remain in good standing.

    There’s a written guarantee behind our engagements too. Ask, and we’ll send you the terms.

    Frequently Asked Questions

    How quickly should a plan of action be submitted?

    Follow the deadline in the notice or corrective-action request. Begin containment and evidence collection immediately. If a deadline cannot be met, communicate through the appropriate channel before it passes and document the reason, interim safeguards, and expected completion date.

    Can staff training alone correct a deficiency?

    Sometimes, but only when training is the true root cause and competency is verified. Most repeated deficiencies also require a policy, workflow, supervision, form, staffing, or monitoring change.

    Who should approve the plan?

    The operational owner should draft the actions, compliance should validate them against requirements, and executive leadership should approve resources and accountability. Governance involvement is appropriate when the issue is material, recurring, or creates significant organizational risk.

    What if our license has already been suspended or revoked?

    Act quickly, preserve records, understand the specific basis for the action, and avoid improvised submissions. A focused investigation, corrective-action strategy, and evidence package can be essential to pursuing reinstatement and restoring good standing.

    A corrective action plan should make the next right action obvious to every person responsible for it. If your organization is facing a survey finding, investigation, licensure threat, accreditation concern, or repeat documentation failure, contact Continued Compliance through the Contact Us page for a free consultation. We help operators replace uncertainty with a plan that can be executed, tested, and defended.

    This content is provided for general informational purposes only and should not be construed as medical, clinical, legal, financial, tax, accounting, insurance, licensing, accreditation, regulatory, billing, employment, or compliance advice. Requirements change often. Consult qualified professionals or contact Continued Compliance, Inc. for guidance specific to your situation. This article was created by the compliance expert cited above and reviewed by AI. A compliance expert approved and edited it for accuracy before publication.

  • Massachusetts License Reinstatement: BSAS Suspension and Hearings

    Massachusetts License Reinstatement: BSAS Suspension and Hearings

    Author: A. Ant, CADC-II, Licensing & Accreditation Expert

    Massachusetts License Reinstatement: BSAS Suspension and the Hearing Process

    Massachusetts gives providers a real, structured path to challenge a licensing action, but it’s a short one, and missing the window matters more than almost anything else in the process.

    Summary suspension moves fast

    Under 105 CMR 164, the Department can summarily suspend a license or approval when circumstances warrant it. Once that notice goes out, the aggrieved provider has 14 calendar days from receipt to submit a written request for a hearing. That’s a hard clock, not a soft guideline. Missing it forecloses the fastest path to challenging the suspension.

    What the hearing actually looks like

    Hearings proceed under M.G.L. c. 30A and 801 CMR 1.01, the Commonwealth’s formal adjudicatory rules. 105 CMR 164 doesn’t spell out a standard of proof, so plan on the case turning on the documents. A hearing officer issues a recommended decision, the Commissioner reviews it, and the Commissioner’s decision constitutes the Department’s final agency decision. From there, a provider has the right to judicial review under M.G.L. c. 30A, § 14.

    Refusal to renew follows a similar track

    For a freestanding licensee, the grounds for refusing to renew sit in 105 CMR 164.019, with Commissioner and judicial review under 164.021, the same final-agency-decision structure. SUD programs operated inside a DMH- or DPH-licensed hospital or clinic follow the parallel Part Three sections, 164.519 and 164.521. For those programs the BSAS Approval (DPH-licensed facilities) or the DMH-facility SUD license (DMH-licensed facilities) rides on the facility’s own license, so trouble with that license can put the SUD program at risk even when the program itself hasn’t done anything wrong.

    What actually helps at hearing

    A hearing officer and the Commissioner reviewing the record are looking at documented evidence, not assurances. A credible defense means demonstrating the underlying issue is actually corrected: policy changes implemented, staff retrained and verified, corrective action sustained over time, not simply that you’ve promised it won’t happen again.

    Where This Fits In

    This covers BSAS suspension, hearings, and reinstatement specifically. See Massachusetts Behavioral Health Licensing for the full picture.

    This content is provided for general informational purposes only and should not be construed as medical, clinical, legal, financial, tax, accounting, insurance, licensing, accreditation, regulatory, billing, employment, or compliance advice. Requirements change often. Consult qualified professionals for guidance specific to your situation.

    Facing a BSAS summary suspension in Massachusetts?

    Sources

  • Massachusetts Mental Health Outpatient Licensing: DPH Clinic Licensure Under 105 CMR 140

    Massachusetts Mental Health Outpatient Licensing: DPH Clinic Licensure Under 105 CMR 140

    Author: A. Ant, CADC-II, Licensing & Accreditation Expert

    Correction, October 2026: an earlier version of this guide said the Department of Mental Health licenses outpatient mental health PHP and IOP programs. DMH’s facility licensing rules at 104 CMR 27 cover inpatient psychiatric facilities. Community outpatient mental health is licensed by the Department of Public Health as a clinic, and this guide has been rewritten to reflect that.

    Massachusetts Mental Health Outpatient Licensing: A DPH Clinic, Not a DMH Program

    The agency name trips people up. The Department of Mental Health licenses inpatient psychiatric facilities, but a freestanding outpatient mental health program in Massachusetts is a clinic, and clinics are licensed by the Department of Public Health under 105 CMR 140.000. The definition is broad: any entity providing ambulatory medical, surgical, dental, physical rehabilitation or mental health services is a clinic, for-profit or not.

    DPH licenses the clinic for specific services. A “Mental Health Service” under 140.020 is a separate, identifiable service providing diagnosis and treatment for mental health conditions, and it can integrate treatment for co-occurring substance use disorder. A “Medical Service” is a different licensed service, and the license only covers what DPH has authorized.

    The exemption most private practices fall under

    The definition of a clinic excludes one or more practitioners in a solo or group practice that is wholly owned and controlled by those practitioners. A group of LICSWs and a psychiatrist who own their practice don’t need a clinic license. Bring in a lay investor or an outside owner, or use “clinic,” “institute” or “dispensary” in the name, and DPH’s January 2024 guidance puts you back inside licensure. That ownership question usually settles whether you’re filing anything at all.

    What a licensed mental health service has to carry

    Sections 140.500 through 140.560 of 105 CMR 140 hold the mental health service standards. Under 140.530(B)(1), the clinic must have on staff or under contract a psychiatrist who is board certified, or eligible for certification, by the American Board of Psychiatry and Neurology or its osteopathic counterpart, and that psychiatrist oversees all medication prescribing and monitoring. The service also has to offer pharmacotherapy as part of its treatment, so a licensed outpatient mental health clinic is never a counseling-only operation on paper.

    Where BSAS comes in

    Substance use treatment adds a second layer. A clinic offering SUD outpatient or day treatment services also needs Bureau of Substance Addiction Services approval under Part Three of 105 CMR 164, which sits on top of the DPH clinic license. Our Massachusetts Drug and Alcohol Outpatient Licensing: BSAS Requirements guide covers that approval.

    Determination of Need

    DPH’s Determination of Need program under 105 CMR 100 reaches capital spending over the expenditure minimum and substantial changes in service by DPH-licensed facilities, clinics included. A modest outpatient build-out usually stays under it, but confirm with DPH before a large renovation rather than assuming outpatient means no DoN.

    Ketamine in a Massachusetts Outpatient Mental Health Clinic

    Based on 105 CMR 140, Massachusetts controlled substance registration law (M.G.L. c. 94C) and the Board of Registration in Nursing’s advisory rulings. DPH hasn’t issued ketamine-specific guidance, so confirm your service mix with DPH before launch.

    The answer depends on which form of ketamine and which kind of entity.

    Spravato fits a licensed mental health service more naturally. Pharmacotherapy is already part of the service, the board-certified psychiatrist required by 140.530 already oversees medication, and esketamine is a psychiatric medication given in the office under the Spravato REMS, with the patient self-administering and staff monitoring for at least two hours. A licensed clinic should still tell DPH it’s adding the service, since 105 CMR 140 has no specific add-a-service form and DPH decides whether its existing authorization covers it.

    IV ketamine is harder. A sub-anesthetic infusion looks more like a medical service than a mental health one, and the clinic’s license is limited to the services DPH authorized. When a clinic provides medical services, 140.313 requires a physician present unless a PA or advanced practice nurse works under written protocols. Expect DPH to want the Medical Service on the license, or plan to run infusions through a practitioner-owned practice that sits outside clinic licensure altogether. Nurses running infusions should be working within the Board of Registration in Nursing’s Advisory Ruling 9101 on medications for sedation and analgesia.

    Either way, a clinic that keeps ketamine or Spravato on site registers with DPH’s Drug Control Program under M.G.L. c. 94C § 7, which makes a registration effective for one year from issuance, on top of its DEA registration. Ketamine for depression doesn’t count toward a BSAS program’s medication for addiction treatment requirements, so keep it out of the SUD program’s protocols.

    Frequently Asked Questions

    Who licenses outpatient mental health programs in Massachusetts?

    The Department of Public Health, as a clinic under 105 CMR 140 with a licensed Mental Health Service. DMH licenses inpatient psychiatric facilities under 104 CMR 27, not community outpatient programs.

    Does a private therapy group need a Massachusetts clinic license?

    Not if it is wholly owned and controlled by the practitioners who work in it. Outside ownership, or names using clinic, institute or dispensary, bring the practice into DPH clinic licensure.

    Does a Massachusetts outpatient mental health clinic need a psychiatrist?

    Yes. 105 CMR 140.530 requires a psychiatrist on staff or under contract who is board certified or eligible in psychiatry, and that psychiatrist oversees all medication prescribing and monitoring.

    Where This Fits In

    This covers outpatient mental health clinic licensure. See Massachusetts Behavioral Health Licensing for BSAS, DMH inpatient licensing and the full picture.

    This content is provided for general informational purposes only and should not be construed as medical, clinical, legal, financial, tax, accounting, insurance, licensing, accreditation, regulatory, billing, employment, or compliance advice. Requirements change often. Consult qualified professionals for guidance specific to your situation.

    Working out whether your Massachusetts practice needs a DPH clinic license?

    Sources

  • Massachusetts Mental Health Inpatient Licensing: DMH Requirements

    Massachusetts Mental Health Inpatient Licensing: DMH Requirements

    Author: A. Ant, CADC-II, Licensing & Accreditation Expert

    Massachusetts Mental Health Inpatient Licensing: DMH Psychiatric Facilities

    Mental health and substance use disorder licensing run through entirely different departments in Massachusetts, and that split matters most at the residential level. Where BSAS handles round-the-clock SUD care under 105 CMR 164, psychiatric facilities are licensed by the Department of Mental Health under M.G.L. c. 19, § 19 and 104 CMR 27. Those rules define the facilities DMH licenses as private psychiatric hospitals, psychiatric units in general hospitals and intensive residential treatment programs for adolescents.

    Correction (October 2026): an earlier version described DMH as licensing adult residential treatment centers and said new residential facilities generally trigger Determination of Need review. Both statements went further than the regulations, and the sections below have been corrected.

    Don’t assume one license covers both

    A facility can be fully DMH-licensed for residential mental health treatment and have no authority whatsoever to provide SUD services, and vice versa. If your population is genuinely co-occurring, a DMH-licensed facility doesn’t go after a freestanding BSAS license. Its SUD program runs through Part Three of 105 CMR 164 (164.500 onward), which covers providers that already hold a DMH or DPH license, and ends in what 105 CMR 164.005 calls a “Substance Use Disorder Treatment License for Department of Mental Health Licensed Facility.” That’s a license issued by DPH, not the “Approval” that programs inside DPH-licensed hospitals and clinics receive. That track only works if the DMH license is already correctly in place.

    What DMH is actually looking for

    Facility licensure under DMH follows its own governance, staffing, and facility standards separate from BSAS’s SUD-specific requirements. Facilities providing psychiatric services specifically may carry additional requirements on top of the base residential licensing standards, and psychiatric service lines aren’t automatically covered by a general residential mental health license.

    Certificate of Need considerations

    Determination of Need under M.G.L. c. 111, § 25C and 105 CMR 100 applies to the health care facilities defined in § 25B, hospitals and clinics among them, when a project crosses the capital expenditure minimum or makes a substantial change in service (for a health care facility that isn’t a hospital, 105 CMR 100.100 counts bed increases once they add up to more than twelve beds). Whether a given psychiatric project is covered depends on the facility type and the project, so put the question to DPH’s DoN program. This is a real, separate planning step from the DMH licensing application itself, and it’s worth confirming early, since a site and program plan built without accounting for DoN review can lose months once the gap surfaces.

    Ketamine and Spravato Under a DMH License

    An interpretation drawn from the DMH licensing structure described above, the separate DPH and BSAS layers and the Spravato REMS. DMH hasn’t published ketamine guidance.

    This page already notes that psychiatric service lines aren’t automatically covered by a general residential mental health license, and ketamine is a good test of that point. A DMH-licensed psychiatric inpatient facility with physicians and nursing on staff can bring ketamine or Spravato in through its medical staff process. A residential treatment program licensed at a lower acuity should ask DMH whether a medical procedure like an infusion fits its license before planning on it, since the service may need its own approval.

    A DMH-licensed residence gives a new ketamine patient staff who see them at breakfast the morning after a session. Those observations become the case for continuing, and the outpatient prescriber who will carry the series past discharge should be agreed on before the first dose. For co-occurring residents, ketamine isn’t an FDA-approved addiction medication, so it doesn’t belong in the SUD protocols a DMH facility submits for BSAS sign-off.

    Spravato adds REMS enrollment and two hours of post-dose observation to the facility’s workload.

    Where This Fits In

    This covers DMH residential mental health licensure specifically. See Massachusetts Behavioral Health Licensing for the full picture.

    This content is provided for general informational purposes only and should not be construed as medical, clinical, legal, financial, tax, accounting, insurance, licensing, accreditation, regulatory, billing, employment, or compliance advice. Requirements change often. Consult qualified professionals for guidance specific to your situation.

    Adding SUD protocols to an existing Massachusetts DMH license?

    Sources

  • Massachusetts Drug and Alcohol Outpatient Licensing: BSAS Requirements

    Massachusetts Drug and Alcohol Outpatient Licensing: BSAS Requirements

    Author: A. Ant, CADC-II, Licensing & Accreditation Expert

    Apply now: General Suitability Notice of Intent | Questions: bsas-noi-suitability@mass.gov

    Massachusetts Drug and Alcohol Outpatient Licensing: BSAS Outpatient Services

    Outpatient SUD treatment in Massachusetts runs through 105 CMR 164.200, and BSAS defines the sub-categories more precisely than a lot of operators expect going in, precise enough that guessing which one describes your program is a real risk.

    Correction (October 2026): earlier versions of the ketamine and medication sections said every BSAS outpatient program sits on a DPH or DMH clinic or hospital license, and described the medication rule as nondiscriminatory access to opioid use disorder drugs under the 2018 CARE Act. Freestanding programs are licensed by BSAS directly, and the rule is the 105 CMR 164.009(B) attestation described below.

    Day Treatment has an actual hour requirement

    Day Treatment isn’t a loose label in Massachusetts. It’s defined as an intensive outpatient program providing direct patient services through group, individual, and family SUD counseling for a minimum of 3.5 hours per day, at least three days a week. If your program doesn’t meet that threshold, BSAS isn’t going to consider it Day Treatment regardless of what you call it internally, and that mismatch matters when your marketing describes a level of care your licensed hours don’t support.

    Outpatient Withdrawal Treatment Service is its own category

    This is ambulatory SUD treatment that clinically manages withdrawal symptoms through medical and ancillary treatment without a 24-hour residential setting. It’s a distinct service type from Day Treatment and from the 24-Hour Diversionary Services covered under inpatient, so don’t assume outpatient withdrawal management and Day Treatment share the same standards just because both happen outside a residential setting.

    Opioid Treatment Programs and MAT access

    Massachusetts goes further than most states on guaranteed medication access, a detail easy to miss. OTPs fall under Part Two of 105 CMR 164 alongside the other specific service categories, and like any program giving medical care they run it under a Medical Director, whom 105 CMR 164.005 makes responsible for all of the program’s medical services. Every license application also carries two attestations under 105 CMR 164.009(B) that matter whether or not you run a dedicated OTP: the program will provide all FDA-approved medications for addiction treatment, directly or through a qualified service organization agreement, and it will serve Massachusetts residents with public health insurance on a nondiscriminatory basis and report its payer mix quarterly, as M.G.L. c. 111E, § 7 requires. Neither is a narrow OTP-only rule. It reflects the same direction other states are moving in around guaranteed MAT access, and it’s worth building into your program design even if medication management isn’t your primary service line.

    Accreditation can count toward compliance

    The “Deemed Status” definition in 105 CMR 164.005 reaches outpatient programs too: the Department’s acceptance of accreditation, from an accrediting body the Commissioner has approved, as evidence of compliance with one or more requirements. The regulation stops at the definition. There’s no list of approved accreditors and no list of covered requirements, so get BSAS to confirm what a CARF or Joint Commission survey counts for in your case. You still file the Notice of Intent either way.

    Central Registry System participation

    If you’re operating an OTP specifically, 105 CMR 164.305 requires participation in the Central Registry System, which verifies medication and dose at admission and keeps a patient from being enrolled in two OTPs at once. It’s an ongoing compliance obligation, not a one-time signup.

    Opening a Ketamine Clinic Next to a Massachusetts Outpatient Program

    Based on DPH’s January 2024 clinic licensure memo, 105 CMR 140 and 105 CMR 164. Massachusetts hasn’t issued ketamine clinic rules, so confirm the structure with counsel and DPH.

    Nothing in Massachusetts law prohibits a stand-alone ketamine clinic, and DPH has spelled out the ownership line more plainly than most states.

    Ownership Routes

    The first route is a practitioner-owned practice. DPH’s January 3, 2024 memo to licensees says an entity offering ambulatory medical services is subject to clinic licensure under 105 CMR 140 unless it’s wholly owned and controlled by its practitioners and doesn’t use terms like “clinic,” “institute” or “dispensary” in its name. A physician-owned professional corporation that calls itself a ketamine clinic has, by that standard, named itself into a licensure requirement. The second route is a DPH-licensed clinic, which can have lay ownership but must meet 105 CMR 140’s staffing and administrative rules, and The same memo warns that missing those staffing rules can cost the clinic license and send individual providers to their licensing boards, and that an unlicensed entity holding itself out as a clinic can be referred to the Attorney General’s Office over deceptive practices. An MSO contracting with a practitioner-owned practice is the third option, for investors who’d rather keep the practice itself outside clinic licensure.

    Next to a BSAS Program

    A BSAS outpatient program that operates inside a DPH-licensed clinic, under a BSAS approval, already has a clinic license underneath it, so an operator may be tempted to run ketamine under that same license. That can work in principle, but the ketamine service needs DPH’s sign-off as an addition to the clinic license and has to stay outside the BSAS-approved SUD program. A freestanding program licensed by BSAS alone has no clinic license to extend, which sends it back to the ownership routes above. Separate records, a separately registered ketamine supply and written 42 CFR Part 2 consent before an addiction treatment record moves over keep the two from blurring. Ketamine also doesn’t count toward the medication attestation described above, which covers FDA-approved addiction medications.

    How to Submit Your BSAS Notice of Intent

    Outpatient programs start with the same General Suitability Notice of Intent process that covers residential and diversionary services, detailed on BSAS’s Information for Initial SUD Program Licensure page. For questions about the suitability and licensing process, BSAS’s contact is bsas-noi-suitability@mass.gov.

    See our Massachusetts Behavioral Health Licensing page for the full picture.

    This content is provided for general informational purposes only and should not be construed as medical, clinical, legal, financial, tax, accounting, insurance, licensing, accreditation, regulatory, billing, employment, or compliance advice. Requirements change often. Consult qualified professionals for guidance specific to your situation.

    Classifying your Massachusetts outpatient program under 164.200? Let’s talk it through.

    Sources

Top